Total raised
€78M
€78,000,000
Funding rounds
2
Investors
7
distinct backers
Active since
2018-12
latest 2025-08
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood45
base rate 48% for Series B
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ €30M+ raised
- ▲ 8y since founding
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-08-07 | Series B | €35M | Cystic Fibrosis Foundation,Existing investors,Lundbeckfonden BioCapital,North-East Family Office,the German Federal Agency for Breakthrough Innovation (SPRIN-D),Wellington Partners | View deal → |
| 2019-01-01 | Series A | €43M | Lundbeckfonden Ventures | View deal → |
Investors
7Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce